跳至主要内容
临床试验/NCT06059170
NCT06059170已完成不适用

Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life

University Hospital, Ghent2 个研究点 分布在 1 个国家目标入组 187 人开始时间: 2017年3月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
187
试验地点
2
主要终点
Assessment QoL

研究概览

简要总结

Quality of life and risk factors for developing major LARS are explored. Therapeutic options were explored in the cohort experiencing major LARS

详细描述

Quality of life and risk factors for developing major LARS are explored using the EORTC QLQ C30. Therapeutic options were explored in the cohort experiencing major LARS

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • low anterior resection for rectal cancer between 2006-2016

排除标准

  • abdomino perineal resection
  • patients who do not understand Dutch

结局指标

主要结局

Assessment QoL

时间窗: up to 10 years after rectal resection

Assessments using questionnaire European Organization for Research and Treatment for Cancer Quality of Life Questionnaire (EORTC QLQ C30)

frequencies of therapeutic options to manage LARS

时间窗: up to 10 years after rectal resection

Self developed questionaire to determine what therapeutic options were used to manage LARS

Frequency of LARS

时间窗: up to 10 years after rectal resection

Assessment of LARS using validated LARS Score

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

GIHeelkunde

Clinical nurse specialist digestive oncology

University Hospital, Ghent

研究点 (2)

Loading locations...

相似试验